Chlorzoxazone
- Product NDC
- 42494-425
- 11-digit product format
- 424940425
- Labeler code
- 42494
- Product ID
- 42494-425_aae5e69e-1a4d-41bc-a08e-89fdfd68b6c7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Chlorzoxazone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Cameron Pharmaceuticals
- Application
- ANDA212254
- Marketing category
- ANDA
- Marketing start
- 2019-11-27
- Marketing end
- 0000-00-00
- Substance
- CHLORZOXAZONE
- Active strength
- 375 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42494-425-08 | 42494042508 | 60 TABLET in 1 BOTTLE, PLASTIC (42494-425-08) | 60 tablet | 2021-01-15 | 0000-00-00 | No | No | Current |
| 42494-425-10 | 42494042510 | 100 TABLET in 1 BOTTLE, PLASTIC (42494-425-10) | 100 tablet | 2019-11-27 | 0000-00-00 | No | No | Current |